Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
   C01 CARDIAC THERAPY
     C01A CARDIAC GLYCOSIDES
     C01B ANTIARRHYTHMICS, CLASS I AND III
     C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
     C01D VASODILATORS USED IN CARDIAC DISEASES
     C01E OTHER CARDIAC PREPARATIONS
       C01EA Prostaglandins
         C01EA01 Alprostadil [DG:DG00239]
           D00180  Alprostadil (JP18/USP/INN) <JP/US>
           D02705  Alprostadil alfadex (JP18) <JP>
       C01EB Other cardiac preparations
       C01EX Other cardiac combination products
   C02 ANTIHYPERTENSIVES
   C03 DIURETICS
   C04 PERIPHERAL VASODILATORS
   C05 VASOPROTECTIVES
   C07 BETA BLOCKING AGENTS
   C08 CALCIUM CHANNEL BLOCKERS
   C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C10 LIPID MODIFYING AGENTS
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
   G02 OTHER GYNECOLOGICALS
   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
   G04 UROLOGICALS
     G04B UROLOGICALS
       G04BA Acidifiers
       G04BC Urinary concrement solvents
       G04BD Drugs for urinary frequency and incontinence
       G04BE Drugs used in erectile dysfunction
         G04BE01 Alprostadil [DG:DG00239]
           D00180  Alprostadil (JP18/USP/INN) <JP/US>
           D02705  Alprostadil alfadex (JP18) <JP>
         G04BE02 Papaverine [DG:DG00043]
         G04BE03 Sildenafil [DG:DG00484]
         G04BE04 Yohimbine [DG:DG00485]
         G04BE06 Moxisylyte [DG:DG00287]
         G04BE07 Apomorphine [DG:DG00486]
         G04BE08 Tadalafil
         G04BE09 Vardenafil [DG:DG00487]
         G04BE10 Avanafil
         G04BE11 Udenafil
         G04BE30 Combinations
         G04BE52 Papaverine, combinations
       G04BX Other urologicals
     G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 22, 2024
According to WHO's ATC 2024

» Japanese version